Terms: = Leukemia AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
14487 results:
1. Effective delivery of anti-PD-L1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines.
Rajabinejad M; Valadan R; Tehrani M; Najafi A; Negarandeh R; Saeedi M; Asgarian-Omran H
Med Oncol; 2024 May; 41(6):149. PubMed ID: 38739199
[TBL] [Abstract] [Full Text] [Related]
2. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
[TBL] [Abstract] [Full Text] [Related]
3. TurboID-Based IRE1 Interactome Reveals Participants of the Endoplasmic Reticulum-Associated Protein Degradation Machinery in the Human Mast Cell leukemia Cell Line HMC-1.2.
Ahmed N; Preisinger C; Wilhelm T; Huber M
Cells; 2024 Apr; 13(9):. PubMed ID: 38727283
[TBL] [Abstract] [Full Text] [Related]
4. The impact of regulatory T cells on the graft-versus-leukemia effect.
Pacini CP; Soares MVD; Lacerda JF
Front Immunol; 2024; 15():1339318. PubMed ID: 38711496
[TBL] [Abstract] [Full Text] [Related]
5. Oxidative Stress: An Intersection Between Radiation and Sulfur Mustard Lung Injury.
Day BJ
Disaster Med Public Health Prep; 2024 May; 18():e86. PubMed ID: 38706344
[TBL] [Abstract] [Full Text] [Related]
6. Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
Eissenberg LG; Ritchey JK; Rettig MP; Patel DA; Vij K; Gao F; Smith V; Han TH; DiPersio JF
PLoS One; 2024; 19(5):e0300174. PubMed ID: 38696390
[TBL] [Abstract] [Full Text] [Related]
7. Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells and diagnostic applications.
Gallo E; Diaferia C; Smaldone G; Rosa E; Pecoraro G; Morelli G; Accardo A
Sci Rep; 2024 Apr; 14(1):9940. PubMed ID: 38688930
[TBL] [Abstract] [Full Text] [Related]
8. In vitro anti-leukemic effect of Wharton's jelly derived mesenchymal stem cells.
Süleymanoğlu M; Erol Bozkurt A; Abatay Sel F; Özdemir İA; Savran Oğuz F; Kuruca DS; Aktaş Z; Karakaş Z; Öncül MO
Mol Biol Rep; 2024 Apr; 51(1):595. PubMed ID: 38683436
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of the
Nasr GM; Thawabieh OM; Talaat RM; Moawad M; El Hamshary MO
Front Biosci (Landmark Ed); 2024 Apr; 29(4):162. PubMed ID: 38682177
[TBL] [Abstract] [Full Text] [Related]
10. Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage.
Yetkin-Arik B; Jansen SA; Varderidou-Minasian S; Westendorp B; Skarp KP; Altelaar M; Lindemans CA; Lorenowicz MJ
Stem Cell Res Ther; 2024 Apr; 15(1):125. PubMed ID: 38679715
[TBL] [Abstract] [Full Text] [Related]
11. Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.
Yáñez-Bartolomé M; Serra-Camprubí Q; Arenas EJ; Escorihuela M; Castet F; Fabregat-Franco C; Querol J; Arribas J; Peiró S; Macarulla T; Tian TV
Methods Mol Biol; 2024; 2806():139-151. PubMed ID: 38676801
[TBL] [Abstract] [Full Text] [Related]
12. Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors.
Alves R; Pires A; Jorge J; Balça-Silva J; Gonçalves AC; Sarmento-Ribeiro AB
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674139
[TBL] [Abstract] [Full Text] [Related]
13. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
[TBL] [Abstract] [Full Text] [Related]
14. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid leukemia Cells In Vitro.
Chen WA; Williams TG; So L; Drew N; Fang J; Ochoa P; Nguyen N; Jawhar Y; Otiji J; Duerksen-Hughes PJ; Reeves ME; Casiano CA; Jin H; Dovat S; Yang J; Boyle KE; Francis-Boyle OL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673926
[TBL] [Abstract] [Full Text] [Related]
15. Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers.
Diepstraten ST; Yuan Y; La Marca JE; Young S; Chang C; Whelan L; Ross AM; Fischer KC; Pomilio G; Morris R; Georgiou A; Litalien V; Brown FC; Roberts AW; Strasser A; Wei AH; Kelly GL
Cancer Cell; 2024 May; 42(5):850-868.e9. PubMed ID: 38670091
[TBL] [Abstract] [Full Text] [Related]
16. [Effect of Shikonin on Autophagy and Apoptosis of Human Promyelocytic leukemia Cells].
Chen Y; Xie XM; Zhang XL; Zhang XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):416-421. PubMed ID: 38660845
[TBL] [Abstract] [Full Text] [Related]
17. [Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid leukemia Cells].
Yu YH; Li HJ; Yang XY; Yu LY; Tong XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):389-394. PubMed ID: 38660841
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient treatment of Acute Myeloid leukemia and Overcoming Resistance of FLT3 Inhibitors.
Wang J; Rong Q; Ye L; Fang B; Zhao Y; Sun Y; Zhou H; Wang D; He J; Cui Z; Zhang Q; Kang D; Hu L
J Med Chem; 2024 May; 67(9):7197-7223. PubMed ID: 38655686
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong
Hu J; Xu H; Wu T; Zhang C; Shen H; Dong R; Hu Q; Xiang Q; Chai S; Luo G; Chen X; Huang Y; Zhao X; Peng C; Wu X; Lin B; Zhang Y; Xu Y
J Med Chem; 2024 May; 67(9):6952-6986. PubMed ID: 38649304
[TBL] [Abstract] [Full Text] [Related]
20. Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid leukemia Cells.
Kobyakova MI; Senotov AS; Krasnov KS; Lomovskaya YV; Odinokova IV; Kolotova AA; Ermakov AM; Zvyagina AI; Fadeeva IS; Fetisova EI; Akatov VS; Fadeev RS
Biochemistry (Mosc); 2024 Mar; 89(3):431-440. PubMed ID: 38648763
[TBL] [Abstract] [Full Text] [Related]
[Next]